Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery in patients with 1-3 newly diagnosed brain metastases.

Manmeet S. Ahluwalia, Samuel T. Chao, Michael W. Parsons, John H. Suh, Ding Wang, Tom Mikkelsen, Cathy J. Brewer, Kathy N. Smolenski, Cathy Schilero, Matthew Rump, Paul Elson, Lilyana Angelov, Gene H. Barnett, Michael A. Vogelbaum, Robert J. Weil, David M. Peereboom

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalJournal of neuro-oncology
Volume124
DOIs
StatePublished - Aug 6 2015

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Surgery
  • Internal Medicine

Cite this